1. Home
  2. IQV vs NUE Comparison

IQV vs NUE Comparison

Compare IQV & NUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IQV
  • NUE
  • Stock Information
  • Founded
  • IQV 1982
  • NUE 1905
  • Country
  • IQV United States
  • NUE United States
  • Employees
  • IQV N/A
  • NUE 32000
  • Industry
  • IQV Biotechnology: Commercial Physical & Biological Resarch
  • NUE Steel/Iron Ore
  • Sector
  • IQV Health Care
  • NUE Industrials
  • Exchange
  • IQV Nasdaq
  • NUE Nasdaq
  • Market Cap
  • IQV 31.6B
  • NUE 25.8B
  • IPO Year
  • IQV 2013
  • NUE N/A
  • Fundamental
  • Price
  • IQV $156.39
  • NUE $103.33
  • Analyst Decision
  • IQV Strong Buy
  • NUE Strong Buy
  • Analyst Count
  • IQV 18
  • NUE 8
  • Target Price
  • IQV $248.72
  • NUE $166.00
  • AVG Volume (30 Days)
  • IQV 1.6M
  • NUE 3.1M
  • Earning Date
  • IQV 05-01-2025
  • NUE 04-28-2025
  • Dividend Yield
  • IQV N/A
  • NUE 2.00%
  • EPS Growth
  • IQV 2.74
  • NUE N/A
  • EPS
  • IQV 7.49
  • NUE 8.46
  • Revenue
  • IQV $15,405,000,000.00
  • NUE $30,734,000,000.00
  • Revenue This Year
  • IQV $4.25
  • NUE $3.84
  • Revenue Next Year
  • IQV $6.17
  • NUE $5.96
  • P/E Ratio
  • IQV $22.38
  • NUE $12.97
  • Revenue Growth
  • IQV 2.81
  • NUE N/A
  • 52 Week Low
  • IQV $166.16
  • NUE $109.61
  • 52 Week High
  • IQV $252.88
  • NUE $203.00
  • Technical
  • Relative Strength Index (RSI)
  • IQV 24.11
  • NUE 25.32
  • Support Level
  • IQV $169.37
  • NUE $117.12
  • Resistance Level
  • IQV $188.39
  • NUE $123.45
  • Average True Range (ATR)
  • IQV 5.33
  • NUE 4.10
  • MACD
  • IQV -1.74
  • NUE -2.18
  • Stochastic Oscillator
  • IQV 2.23
  • NUE 3.97

About IQV IQVIA Holdings Inc.

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

About NUE Nucor Corporation

Nucor Corp manufactures steel and steel products. The company also produces direct reduced iron for use in its steel mills. The operations include international trading and sales companies that buy and sell steel and steel products manufactured by the company and others. The operating business segments are: steel mills, steel products, and raw materials, the steel mills segment derives maximum revenue. The steel mills segment includes carbon and alloy steel in sheet, bars, structural and plate; steel trading businesses; rebar distribution businesses; and Nucor's equity method investments in NuMit and NJSM.

Share on Social Networks: